Sun Pharma Cleared To Resume Drug Production At Two U.S. Facilities
This article was originally published in PharmAsia News
Executive Summary
The U.S. unit of Sun Pharmaceutical Industries, Caraco Pharmaceuticals Laboratories, has received U.S. FDA permission to resume partial operations at two factories in Michigan.